Journey Medical (DERM) Raw Materials (2021)

Journey Medical (DERM) posted Raw Materials of $5.6 million for Q4 2021, up 2.18% on a QoQ basis from $5.5 million in Q3 2021.

Journey Medical (DERM) Raw Materials (2021) Analysis & Trends

Journey Medical's Raw Materials history runs 1 years deep, the most recent figure standing at $5.6 million for Q4 2021.

  • Quarterly Raw Materials changed N/A year-over-year to $5.6 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $5.6 million (changed N/A YoY) and the FY2021 annual result came in at $5.6 million, changed N/A from the prior year.
  • Raw Materials was $5.6 million for Q4 2021 at Journey Medical, up from $5.5 million in the prior quarter.
  • Across five years, Raw Materials topped out at $5.6 million in Q4 2021 and bottomed at $5.5 million in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Journey Medical 179.67 Mn 152.45 Mn 9.70 Mn

Historic Data

Download Data
DateValue
Dec 31, 2021 5.57 Mn
Sep 30, 2021 5.45 Mn